Perturbations in B cell responsiveness to CD4+T cell help in HIV-infected individuals
- 13 May 2003
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 100 (10) , 6057-6062
- https://doi.org/10.1073/pnas.0730819100
Abstract
HIV infection induces a wide array of B cell dysfunctions. We have characterized the effect of plasma viremia on the responsiveness of B cells to CD4(+) T cell help in HIV-infected patients. In HIV-negative donors, B cell proliferation correlated with CD154 expression on activated CD4(+) T cells and with the availability of IL-2, whereas in HIV-infected viremic patients, reduced B cell proliferation was observed despite normal CD154 expression on activated CD4(+) T cells. Reduced triggering of B cells by activated CD4(+) T cells was clearly observed in HIV-infected viremic patients compared with aviremic patients with comparable CD4(+) T cell counts, and a dramatic improvement in B cell function was observed in patients whose plasma viremia was controlled by effective antiretroviral therapy. The degree of B cell dysfunction in viremic patients correlated strongly with the inability of B cells to express CD25 in response to activated CD4(+) T cells, resulting in an inability to mount a normal proliferative response to IL-2. Similar defects in responsiveness to IL-2 were observed in the B cells of HIV-infected viremic patients in the context of B cell receptor stimulation. These data provide new insight into the mechanisms associated with ineffective humoral responses in HIV disease.Keywords
This publication has 48 references indexed in Scilit:
- Abnormal CD40 Ligand (CD154) Expression in Human Immunodeficiency Virus-Infected ChildrenClinical and Diagnostic Laboratory Immunology, 2001
- Potent Antiretroviral Therapy Initiates Normalization of Hypergammaglobulinemia and a Decline in HIV Type 1-Specific Antibody ResponsesAIDS Research and Human Retroviruses, 2001
- The Prognostic Significance in HIV Infection of Immune Activation Represented by Cell Surface Antigen and Plasma Activation Marker ChangesClinical Immunology, 1999
- HIV-1 Antigen–specific and –nonspecific B Cell Responses Are Sensitive to Combination Antiretroviral TherapyThe Journal of Experimental Medicine, 1998
- CD40 AND CD154 IN CELL-MEDIATED IMMUNITYAnnual Review of Immunology, 1998
- HIV Disease in Children Is Associated with a Selective Decrease in CD23+ and CD62L+ B CellsClinical Immunology and Immunopathology, 1996
- The Ability of CD4+ Cells from HIV+ Individuals to Express CD40 Ligand after in Vitro Stimulation Is Not ImpairedClinical Immunology and Immunopathology, 1995
- Lymphocyte responses and cytokinesCell, 1994
- Patients with HIV infection have a reduced proportion of lymphocytes expressing the IL2 receptor p55 chain (TAC, CD25)Clinical Immunology and Immunopathology, 1991
- Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1983